Here's what we at Klinic recommend considering: Semaglutide might be better if: You have better insurance coverage for it You want a medication with a longer track record You prefer to start with something that might have a slightly gentler introduction period You'd rather take a pill than inject the Wegovy pill makes that possible You've responded well to GLP-1 medications in the past Tirzepatide might be better if: You're looking for maximum weight loss potential You want a medication developed specifically for weight loss You're willing to potentially deal with slightly more nausea initially You want a dual-action approach Your insurance covers it or you have budget flexibility Questions to ask yourself: What's your weight loss goal
However, its crucial that they dont operate in a vacuum
The Fine Print on the Medicare GLP-1 Bridge A few things to know before you plan around this: The $50 doesnt count toward your Part D out-of-pocket max
While this has not been confirmed in humans, retatrutide, like semaglutide and tirzepatide, is generally not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Many times they dont know what the side effects or what the adverse effects may be. Richardson said the Form Health doctors will review each patients medical records, including any existing medications that the patient is taking
In the future, multitargeted drugs, novel delivery technologies, and individualized treatments may propel them to become breakthrough therapies for a wider range of diseases